Gimbal Financial Abbott Laboratories Transaction History
Gimbal Financial
- $122 Billion
- Q1 2024
A detailed history of Gimbal Financial transactions in Abbott Laboratories stock. As of the latest transaction made, Gimbal Financial holds 2,904 shares of ABT stock, worth $297,166. This represents 0.27% of its overall portfolio holdings.
Number of Shares
2,904
Previous 2,903
0.03%
Holding current value
$297,166
Previous $320 Million
3.31%
% of portfolio
0.27%
Previous 0.32%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,130Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$16.9 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.6 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.59 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.65 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.18 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $179B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...